US non-profit health insurer Highmark has added, to the items covered by its insurance policies, the Nerivio Remote Electrical Neuromodulation (REN) migraine band, developed by Israel’s Theranica (see here previously). Highmark covers around 7 million people in the Pennsylvania area. … Continue reading →

Israel’s Theranica (see here previously) has reported successful long-term use of its Nerivio Remote Electrical Neuromodulation (REN) device for 409 migraine sufferers in the US. It consistently gave pain relief, functional disability relief and freedom. https://www.prnewswire.com/news-releases/new-study-demonstrates-consistent-positive-long-term-adherence-and-efficacy-of-nerivio-for-treatment-of-migraine-301966050.html

The Nerivio device from Israeli startup Theranica (see here previously) already has US FDA approval to treat acute migraines. It has now been approved for preventing migraines. Recent trials of 248 participants showed a huge improvement for those using Nerivio … Continue reading →

2,500+ US physicians have prescribed the Nerivio migraine relief device from Israel’s Theranica, benefiting some 35,000 Americans with its neuromodulation technology. https://www.timesofisrael.com/spotlight/us-doctors-offer-drug-free-migraine-relief-from-israeli-startup/ https://www.youtube.com/watch?v=-tbRRWVi1q4

The Nerivio therapeutic wearable for treating migraine pain from Israel’s Theranica (see here previously) won “Best New Technology Solution for Pain Management” award in the 2021 MedTech Breakthrough Awards program. It beat more than 3,850 nominations from 17 countries. https://unitedwithisrael.org/israelis-invent-first-wearable-migraine-device-for-acute-pain/

Israel’s Theranica (reported here previously) has received US FDA clearance to market its Nerivio therapeutic device for the acute treatment of episodic or chronic migraine in people 12 years and older. Theranica’s migraine patch was approved by the FDA in … Continue reading →

The Nerivio migraine-zapping wearable device from Israel’s Theranica has already been reported (see here) as one of Time Magazine’s 100 Best Inventions for 2019. Now it has been selected by US research company CB Insights as one of 36 game-changing … Continue reading →

I reported previously (Oct 2016) on the Nerivio Migra smart patch from Israel’s Theranica to provide migraine relief. Since then, Theranica has successfully completed a 12-center pivotal study of the patch and has raised $35 million for US FDA approval … Continue reading →

Israeli startup Theranica Bio-Electronics has developed Nerivio Migra – the first of its “smart patches” delivering neuromodulation therapy – to provide migraine relief.  A recent study of 86 patients at Haifa’s Rambam Medical Center showed promising results. https://www.prnewswire.com/news-releases/american-academy-of-neurology-releases-to-the-press-the-results-of-theranicas-pilot-clinical-study-for-acute-treatment-of-migraine-615210274.html